Change Agents Corporation.

The filing by Avalon GloboCare Corp., a Delaware corporation (the “Company”), of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Quarterly Report”) will be delayed due to the additional time that was required to obtain and compile certain information required to be included in the Quarterly Report, which delay could not be eliminated by the Company without unreasonable effort and expense. The Company expects to file the Quarterly Report within the five calendar day extension period

Avalon GloboCare Corp., a Delaware corporation (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 by the prescribed due date without unreasonable effort or expense because of the circumstances described below. Additional time is needed because the financial statements could not be completed in sufficient time to solicit and obtain the necessary review and approval of the Quarterly Report on Form 10-Q, in a timely fashion prior to the prescribed due date. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 will be filed on or before the 5th calendar day following the prescribed due date

Avalon GloboCare Corp., a Delaware corporation (the “Company”) is unable to file its Annual Report on Form 10-K for the year ended December 31, 2023 by the prescribed due date without unreasonable effort or expense because of the circumstances described below. The Company is unable to file, without unreasonable effort or expense, its Annual Report on Form 10-K for the year ended December 31, 2023 by the prescribed due date. Additional time is needed for the Company to compile and analyze supporting documentation related to its equity investment in Laboratory Services MSO, LLC. The Company expects to report a material weakness in its internal controls over financial reporting and its disclosure controls and procedures. In accordance with Rule 12b-25 of the Securities Exchange Act of 1934, as amended, the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 will be filed on or before the 15th calendar day following the prescribed due date

Avalon GloboCare Corp. (the “ Company ”) has determined that it is unable to file the Form 10-Q for the quarter ended March 31, 2023 (the “ Form 10-Q ”) within the prescribed time period without unreasonable effort or expense because it requires additional time to complete its financial statement preparation and review process. The Company’s recently completed acquisition of forty percent (40%) of all the issued and outstanding equity interests of Laboratory Services MSO, LLC (the “ Laboratory Services Acquisition ”) required additional time to assess the accounting and review for purposes of inclusion in the Form 10-Q. Although the assessment is not yet complete, the Company expects to report material weaknesses in its internal controls over financial reporting and its disclosure controls and procedures. The Company intends to file the Form 10-Q within the five-day grace period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended